Aprepitant

NDC 68462-583 · Glenmark Pharmaceuticals Inc., USA

Generic nameAprepitant

Dosage formCAPSULE

RouteORAL

Active ingredient(s)APREPITANT

Strength40 mg/1

Pharmacologic classCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

68462-583-11 — 1 BLISTER PACK in 1 CARTON (68462-583-11) / 10 CAPSULE in 1 BLISTER PACK

68462-583-40 — 1 BLISTER PACK in 1 CARTON (68462-583-40) / 1 CAPSULE in 1 BLISTER PACK

68462-583-85 — 5 BLISTER PACK in 1 CARTON (68462-583-85) / 1 CAPSULE in 1 BLISTER PACK

Billed under HCPCS

J8501 — Aprepitant, oral, 5 mg Medicare Part B payment limit (ASP + 6%): $3.07

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0006-0461 — aprepitant, 0006-0462 — aprepitant, 0006-0464 — aprepitant, 0006-3066 — aprepitant, 0781-2321 — aprepitant, 0781-2322 — aprepitant, 0781-2323 — aprepitant, 13668-591 — APREPITANT, 13668-592 — APREPITANT, 13668-593 — APREPITANT, 47426-201 — aprepitant, 47426-401 — APREPITANT, 51407-701 — APREPITANT, 51407-702 — APREPITANT, 51407-703 — APREPITANT, 68001-666 — Aprepitant, 68001-667 — Aprepitant, 68001-668 — Aprepitant, 68462-584 — Aprepitant, 68462-585 — Aprepitant

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.